Kevin Kwei

2.5k total citations · 1 hit paper
27 papers, 1.6k citations indexed

About

Kevin Kwei is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Kevin Kwei has authored 27 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Genetics and 8 papers in Oncology. Recurrent topics in Kevin Kwei's work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cancer Genomics and Diagnostics (4 papers). Kevin Kwei is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cancer Genomics and Diagnostics (4 papers). Kevin Kwei collaborates with scholars based in United States, Spain and Italy. Kevin Kwei's co-authors include Jonathan R. Pollack, Keyan Salari, Pei Wang, Tina Hernandez‐Boussard, John D. Minna, Luc Girard, Adi F. Gazdar, Melanie Bocanegra, Jessica Kao and Yoon‐La Choi and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Kevin Kwei

27 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery

2009 611 citations Jessica Kao, Keyan Salari et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin Kwei United States	17	907	598	412	257	216	27	1.6k
Haluk Yuzugullu France	10	1.4k 1.5×	541 0.9×	305 0.7×	169 0.7×	307 1.4×	12	1.8k
Abbas Fotovati Canada	24	1.2k 1.3×	529 0.9×	320 0.8×	148 0.6×	146 0.7×	35	1.7k
Josh Lauring United States	22	1.4k 1.5×	515 0.9×	510 1.2×	137 0.5×	272 1.3×	42	2.0k
Rebecca E. Schweppe United States	25	1.2k 1.4×	765 1.3×	360 0.9×	232 0.9×	191 0.9×	48	2.3k
Jung-Sik Kim United States	26	1.5k 1.7×	596 1.0×	406 1.0×	188 0.7×	313 1.4×	45	2.2k
Ricardo Sánchez‐Prieto Spain	26	1.3k 1.5×	696 1.2×	374 0.9×	174 0.7×	272 1.3×	74	2.1k
Anette Sommer Germany	25	1.2k 1.3×	699 1.2×	323 0.8×	93 0.4×	189 0.9×	63	2.0k
Yongdong Feng China	26	972 1.1×	641 1.1×	397 1.0×	157 0.6×	176 0.8×	64	1.7k
Adriana Aguilar‐Mahecha Canada	19	835 0.9×	420 0.7×	637 1.5×	115 0.4×	169 0.8×	43	1.7k
Ludovica Ciuffreda Italy	21	1.4k 1.5×	668 1.1×	549 1.3×	220 0.9×	373 1.7×	41	2.0k

Countries citing papers authored by Kevin Kwei

Since Specialization

Citations

This map shows the geographic impact of Kevin Kwei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Kwei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Kwei more than expected).

Fields of papers citing papers by Kevin Kwei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Kwei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Kwei. The network helps show where Kevin Kwei may publish in the future.

Co-authorship network of co-authors of Kevin Kwei

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Kwei. A scholar is included among the top collaborators of Kevin Kwei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Kwei. Kevin Kwei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Woyach, Jennifer A., Paolo Ghia, John C. Byrd, et al.. (2023). B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy. Clinical Cancer Research. 29(16). 3065–3073. 7 indexed citations

Moreno, Carol, Richard Greil, Fatih Demırkan, et al.. (2022). First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab <i>versus</i> chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial. Haematologica. 107(9). 2108–2120. 79 indexed citations

Wilson, Wyndham H., Tycel Phillips, Leslie Popplewell, et al.. (2021). Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma*. Leukemia & lymphoma. 62(9). 2094–2106. 3 indexed citations

Noy, Ariela, Sven de Vos, Morton Coleman, et al.. (2020). Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis. Blood Advances. 4(22). 5773–5784. 63 indexed citations

Clarke, Nicole, Kevin Kwei, Jean M. Davidson, et al.. (2015). Integrative Genomics Implicates EGFR as a Downstream Mediator in NKX2-1 Amplified Non-Small Cell Lung Cancer. PLoS ONE. 10(11). e0142061–e0142061. 18 indexed citations

Kwei, Kevin, Joffre Baker, & Robert J. Pelham. (2012). Modulators of Sensitivity and Resistance to Inhibition of PI3K Identified in a Pharmacogenomic Screen of the NCI-60 Human Tumor Cell Line Collection. PLoS ONE. 7(9). e46518–e46518. 40 indexed citations

Kwei, Kevin, A. Hunter Shain, Ryan J. Bair, et al.. (2011). SMURF1 Amplification Promotes Invasiveness in Pancreatic Cancer. PLoS ONE. 6(8). e23924–e23924. 41 indexed citations

Kwei, Kevin, Y. F. Kung, Keyan Salari, Ilona N. Holcomb, & Jonathan R. Pollack. (2010). Genomic instability in breast cancer: Pathogenesis and clinical implications. Molecular Oncology. 4(3). 255–266. 98 indexed citations

Kao, Jessica, Keyan Salari, Melanie Bocanegra, et al.. (2009). Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery. PLoS ONE. 4(7). e6146–e6146. 611 indexed citations breakdown →

10.

Kim, Youn H., Kevin Kwei, Luc Girard, et al.. (2009). Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer. Oncogene. 29(10). 1421–1430. 61 indexed citations

11.

Bergamaschi, Anna, Young H. Kim, Kevin Kwei, et al.. (2008). CAMK1D amplification implicated in epithelial–mesenchymal transition in basal‐like breast cancer. Molecular Oncology. 2(4). 327–339. 43 indexed citations

12.

Kwei, Kevin, Murali Dharan Bashyam, Jessica Kao, et al.. (2008). Genomic Profiling Identifies GATA6 as a Candidate Oncogene Amplified in Pancreatobiliary Cancer. PLoS Genetics. 4(5). e1000081–e1000081. 82 indexed citations

13.

Kwei, Kevin, Y. H. Kim, Luc Girard, et al.. (2008). Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene. 27(25). 3635–3640. 167 indexed citations

14.

Cress, Anne E., et al.. (2008). Integrin A6 Cleavage in Mouse Skin Tumors. PubMed. 2(1). 1–4. 4 indexed citations

15.

Kwei, Kevin, Murali Dharan Bashyam, Anirban Maitra, et al.. (2007). Role of SMURF1 amplification in pancreatic oncogenesis. Cancer Research. 67. 4435–4435. 2 indexed citations

16.

Finch, Joanne S., Margaret E. Tome, Kevin Kwei, & G. Tim Bowden. (2005). Catalase reverses tumorigenicity in a malignant cell line by an epidermal growth factor receptor pathway. Free Radical Biology and Medicine. 40(5). 863–875. 27 indexed citations

17.

Kwei, Kevin, Joanne S. Finch, James Ranger‐Moore, & G. Tim Bowden. (2005). The role of Rac1 in maintaining malignant phenotype of mouse skin tumor cells. Cancer Letters. 231(2). 326–338. 23 indexed citations

18.

Kwei, Kevin, Joanne S. Finch, Eric J. Thompson, & G. Tim Bowden. (2004). Transcriptional Repression of Catalase in Mouse Skin Tumor Progression. Neoplasia. 6(5). 440–448. 46 indexed citations

19.

Butts, Brent D., Kevin Kwei, G. Tim Bowden, & Margaret M. Briehl. (2003). Elevated basal reactive oxygen species and phospho‐Akt in murine keratinocytes resistant to ultraviolet B–induced apoptosis. Molecular Carcinogenesis. 37(3). 149–157. 16 indexed citations

20.

Gupta, Ashok, Brent D. Butts, Kevin Kwei, et al.. (2001). Attenuation of catalase activity in the malignant phenotype plays a functional role in an in vitro model for tumor progression. Cancer Letters. 173(2). 115–125. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact